Fresenius logo

Fresenius

FSNUY | OTC
Chart Builder DCF Calculator
$14.79
-$0.01 (-0.07%)
At close: Nov 16, 2026, 3:53 PM ET
$14.81
+$0.02 (+0.14%)
After-hours: Nov 16, 2026, 3:50 PM ET
-0.07%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 14, 2026
44.9
Fundamentals Average
Market Sentiment Neutral
Moat Narrow
Sector Rank #391/1021 (Top 38%)

Key Statistics

Market Data

Market Cap $24.84B
1D Range
14.79 15.01
52W Range
10.40 15.40

Valuation (TTM)

PE 13.35
PB 1.07
EV/EBITDA 8.63

Valuation (NTM)

Forward PE 14.79
Forward PEG 3.43
Price Target $9.30
Loading financial charts...

Profile

Fresenius SE & Co. KGaA is a healthcare group, which engages in the provision of products and services for dialysis, hospitals, and outpatient medical care. It operates through the following segments:...

Sector Healthcare
Employees 178,394
IPO Date May 15, 2012
Fiscal Year January - December

Latest News

Fresenius SE & Co. KGaA (FSNUY) Q3 2026 Earnings Call Transcript

13 days ago · seekingalpha.com

Fresenius SE & Co. KGaA (FSNUY) Q3 2026 Earnings Call Transcript

2 months ago · zacks.com

Are Investors Undervaluing Fresenius SE & Co. (FSNUY) Right Now?
Waltz Health and Fresenius Kabi Expand Direct Access to Biosimilars Through Waltz Connect Platform

2 months ago · prnewswire.com

Waltz Health and Fresenius Kabi Expand Direct Access to Biosimilars Through Waltz Connect Platform
Should Value Investors Buy Fresenius SE & Co. (FSNUY) Stock?

2 months ago · zacks.com

Should Value Investors Buy Fresenius SE & Co. (FSNUY) Stock?

Earnings

Latest Earnings
Nov 4, 2026
EPS
$0.25
Beat +15.96%
REV
$6.52B
Beat +0.19%
Next Earnings
Feb 24, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.